drugset / Trial / NCT03906344

Expanded Access Use of INCB052793 to Treat a Single Patient With Myelofibrosis

NCT03906344

Expanded access No longer available Incyte Corporation

Summary

Expanded access use of INCB052793 to treat a single patient with Myelofibrosis.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject INCB052793 Unknown

Indications

No indication recorded.